Monitoring & Digital · Note 10
How AI-enabled CCTA assessments help cardiologists and radiologists fight back against plaque
Advanced coronary CT angiography is becoming a routine tool for evaluating suspected coronary artery disease, and the source highlights its role in plaque assessment ahead of a dedicated webinar.
Coronary CT angiography has shifted from a rule-out test used in a narrow group of patients to something closer to a workhorse for people with suspected coronary artery disease. The scan produces a three-dimensional picture of the arteries, and the information it carries extends well beyond whether a vessel is narrowed.
The part drawing the most attention now is plaque characterisation. Software built on top of the scan can help cardiologists and radiologists look at plaque burden and composition rather than only at the degree of stenosis, which is the kind of detail that shapes decisions about preventive therapy and further testing.
Cardiovascular Business frames the topic through an upcoming webinar that will go deeper into how these assessments fit into daily practice. Readers who want the case for the modality, and the caveats that come with it, should read the original item and the webinar material it points to.
Keep in mind
- Plaque assessment goes beyond measuring narrowing.
- The source item previews a webinar on practical use.
Source and reuse
This is an independent editorial summary written for Heartline. It is not a verbatim reproduction and does not reproduce paywalled text. Reporting, data and quotations belong to Cardiovascular Business. Read the original at the link provided.
Metadata basis: the publisher’s public RSS feed and the abstract it exposes. Where the full article could not be accessed, this note is explicitly metadata-based and limited to what the feed disclosed. It is not medical advice.
Read the original at Cardiovascular Business →